Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Over the past decade, the CMS has introduced numerous value-based policy initiatives.
Why it matters
This symposium summary describes planned talks on how Medicare policy and payment changes affect older adults with high care needs, including those with dementia receiving home care. It presents no results on treating, curing, or preventing Alzheimer's disease.
-
The Healthcare Effectiveness Data and Information Set provides the dominant quality measurement framework for Medicare Advantage and commercial health plans, yet HEDIS lacks validated geriatric-specific quality indicators, equitable measurement standards for diverse older adult populations, and governance controls calibrated to the high-stakes Star Ratings financial incentive context.
Why it matters
This paper proposes a governance framework for geriatric quality measures, including cognitive impairment screening, in Medicare Advantage plans. It does not address treating, curing, or preventing Alzheimer's disease.
-
Empowering family caregivers of patients with ADOD in a personalized DCEP provides durable reductions in patient hospitalizations and medical costs.
Why it matters
This pragmatic trial of a digital caregiver empowerment program for family caregivers of Medicare Advantage patients with Alzheimer's disease and related dementias reported reductions in avoidable patient hospitalizations that were durable through 9 months. It suggests that supporting caregivers through education, coaching, and remote monitoring may help reduce hospital use, though it does not test a treatment or cure for the disease itself.
-
Fortunately, in our experience, five of the six patients were likely to be satisfied with these digital experiences.
Why it matters
This small experience of six patients with end-stage heart failure used digital home visits, and five were likely satisfied while one with major neurocognitive disorders had a neutral response. It is preliminary and does not test any treatment, cure, or prevention for Alzheimer's disease.
-
We investigate and find strong evidence that cross-state differences in gender inequality are significantly associated with the gender gap in cognition.
Why it matters
Across Indian states, higher levels of gender inequality were linked to a larger gap in cognitive test performance between women and men. The study suggests social conditions like education, early marriage, and labor force participation are connected to this gap, but it does not test any treatment or prevention.
-
Overall cancer mortality rates were 12.3% higher in persistent poverty counties versus all others, and 9.6% higher in persistent versus current poverty counties, with even greater disparities observed for specific cancer sites.
Why it matters
This summary highlights a study finding that higher levels of plasma amyloid-beta were linked to higher cancer risk, suggesting a possible biological link between Alzheimer's disease and cancer. It does not test any treatment, cure, or prevention for Alzheimer's disease.
-
Many S/THOs focus on improving chronic disease risk factors because of the significant human burden and cost of these conditions.
Why it matters
This paper describes a framework to help state health officials prioritize policies addressing chronic disease risk factors. It contains no findings on treating, curing, or preventing Alzheimer's disease.
-
The decision of whether to utilize CI results from a shared decision-making process involving patients and their providers.
Why it matters
This paper examines the cost-effectiveness of cochlear implants for adults with hearing loss, including older adults. It contains no information about treating, curing, or preventing Alzheimer's disease.
-
27/100
He was just another old man in a busy emergency department during my clinical attending shift.
Why it matters
This essay describes an older man with a broken wrist and jaw who could not give his address but remembered his wife. It contains no findings on treating, curing, or preventing Alzheimer's disease.
-
A growing population of individuals with multimorbidity, cognitive impairment and functional decline live in the community but are homebound, defined as rarely or never leaving home.
Why it matters
In this study of 7042 older adults, neighborhood factors such as nursing home bed availability, primary care providers, and walkability did not affect the risk of becoming homebound. High neighborhood socioeconomic status was protective, but this relationship weakened in fully adjusted models and was not statistically significant.
-
The law has safeguards intended to ensure that patients are acting autonomously, including a 15-day waiting period between two requests, the requirement that patients meet privately with their physicians to confirm they are acting on their own, and the requirement that patients sign a form within 48 hours of taking the aid-in-dying drug to indicate that it is their choice.
Why it matters
This article discusses considerations for pharmacists as California implements its physician aid-in-dying law. It contains no information about treating, curing, or preventing Alzheimer's disease.
-
He has been actively delivering lectures on the prevention of diseases associated with adult lifestyle habits and the preservation of the global environment via ‘shokuiku,’ or food education.
Why it matters
This lecture summary discusses food education and hospital meal times and lighting, with no investigation of Alzheimer's disease. It provides no evidence for treating, curing, or preventing Alzheimer's.
-
Medication-related health problems in the Korean elderly have been increasing very rapidly in Korea with the population of the aged increased.
Why it matters
This study describes the development of a pictorial, web-based education program to help elderly people with cognitive impairment understand medication instructions. It does not test any treatment, cure, or prevention for Alzheimer's disease.
-
Agents currently in use against human immunodeficiency virus (HIV) infection, including the prospects of a vaccine, have focused primarily on destroying or disabling the virus.
Why it matters
This review paper discusses mechanisms by which lithium salts might boost defence against viral infections and increase neuroprotective proteins, with possible relevance to AIDS-related dementia. It is a review of mechanisms and case reports, not a trial, so it does not establish that lithium treats or prevents dementia.
-
Gaining competitive advantage in retailing requires knowledge of the attributes consumers use to evaluate stores and an understanding of why these attributes are important.
Why it matters
This study used repertory grid methodology to compare store images among loyal customers of three UK grocery retailers. It has no relevance to treating, curing, or preventing Alzheimer's disease.
-
Para psychotic troubles in Mentally Handicapped Persons (particularly in Down syndrome)-Clinical examples of M.H.P. which had no trouble until their 25-40 (years) except their intellectual defect and then, slide in psychiatric or para psychiatric behaviour.
Why it matters
This clinical report describes psychiatric and behavioural changes in adults with intellectual disability, particularly Down syndrome, and mentions pseudo intellectual deterioration sometimes considered almost Alzheimer-like. It offers observations and thoughts on prevention of psychological loss of control, not any treatment, cure or prevention for Alzheimer's disease.
-
27/100
Contrary to the experience at the Crichton Royal, our major difficulty is providing in-patient beds for the functionally ill, which again may be a local problem.
Why it matters
This commentary discusses the difficulty of providing in-patient beds for functionally ill older people and argues that long-term dementia care need not be in a hospital ward. It warns that focusing on long-term dementia beds may cause the problem of acute functional illness to be forgotten.
-
This study sought to test the hypothesis that adults with Down Syndrome may age faster than the general population by comparing the rate of increase in their mortality with age with that of the general population by the method originally described by Gompertz.
Why it matters
This study compared mortality rates with age in adults with Down syndrome and the general population and found no statistically significant difference. It reports no treatment, cure or prevention effect for Alzheimer's disease.
-
Long-term care insurance (LTCI) is commonly understood as a social insurance mechanism that compensates care-related costs after disability has occurred.
Why it matters
This article argues that long-term care insurance in China should move upstream to identify functional risk earlier through comprehensive geriatric assessment and caregiver support, noting that existing quasi-experimental studies show only partial benefits. The authors state these studies do not establish the effectiveness of such a model, and the article does not test any cure or prevention.
-
Lecanemab ist eine Anti-Amyloid-Antikörper-Therapie, die entwickelt wurde, um toxische Amyloid-Plaques zu beseitigen und das Fortschreiten der Alzheimer-Krankheit zu verlangsamen.
Why it matters
This report states that lecanemab is an anti-amyloid antibody therapy developed to remove toxic amyloid plaques and slow Alzheimer's progression. Belgian researchers used an Alzheimer's mouse model to investigate the mechanisms driving antibody-induced amyloid clearance, so the work is preclinical.
-
In 2026, the beginning of the 15th Five-Year Plan, the Central No. 1 Document emphasized the cultivation and expansion of county-level wealth-creating industries as the core approach to ensuring stable income growth for farmers.
Why it matters
This case study describes a rural revitalization model for county-level industries in China. It provides no information on treating, curing or preventing Alzheimer's disease.
-
Current processes for identifying hospice-eligible residents rely on regular assessments and interdisciplinary collaboration but reveal significant gaps, including delays in referrals and inconsistent practices.
Why it matters
Stakeholders in this qualitative study viewed ADEPT as a promising tool to complement goals-of-care conversations and enhance care planning for nursing home residents with dementia, rather than as a trigger for hospice alone. Barriers such as electronic system integration and staff education must be addressed before implementation, and the tool is not a treatment, cure, or prevention for Alzheimer's disease.
-
Down syndrome is one of the most common chromosomal abnormalities in humans in which an extra copy of chromosome 21 is present.
Why it matters
This case report describes evaluating memory changes in a 44-year-old man with Down syndrome, noting that chromosome 21 carries the amyloid precursor protein gene, which raises Alzheimer's risk. It emphasizes the need for tailored assessments to detect dementia early in people with Down syndrome.
-
Preliminary findings suggest these adaptations improved nursing assistant engagement, consistency in strategy use, and resident interaction quality.
Why it matters
A prior feasibility study found that speech-language pathologists could train nursing assistants in communication strategies, with significant reductions in behavioral distress among residents. This work is about improving communication and care in nursing homes, not about treating, curing, or preventing Alzheimer's disease itself.
-
Compared to direct estimation, the HB SAE model reduced the number of sub-districts with Relative Standard Errors (RSE) above 25% from 55 to 44, achieving lower Mean Squared Error (MSE) values and more stable estimates.
Why it matters
This study is about statistical estimation of stunting prevalence at the subdistrict level, not Alzheimer's disease, so it does not provide information on treating, curing or preventing Alzheimer's. It found that incorporating spatial effects improved the precision of stunting estimates.
From across this topic
10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Enhancing shared and surrogate decision making for people living with dementia: A systematic review of the effectiveness of interventions
- To tell or not to tell-comparison of older patients' reaction to their diagnosis of dementia and depression
- What Does a Post-Pandemic Presidency Mean for Medicare?
- Mixed brain pathologies account for most dementia cases in community-dwelling older persons
- Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage
- Pilot Test of Aprendiendo Juntos/Learning Together Demonstrates Improved Self-Efficacy for Providing Care Among Latino Family Caregivers of Persons Living With Dementia
- Experimental models of vascular dementia and vascular cognitive impairment: a systematic review
- Gait and cognition: a complementary approach to understanding brain function and the risk of falling
- MMSE-Based Dementia Prediction: Deep vs. Traditional Models
- Remote Neuropsychological Assessment in Rural American Indians with and without Cognitive Impairment